Utilization management in toxicology

被引:13
作者
Zhang, Yan [1 ]
Kwong, Tai C. [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
关键词
Utilization management; Toxicology; Emergency department; Pain management; Urine drug testing; Reimbursement; CHRONIC NONCANCER PAIN; ETHYLENE-GLYCOL; PRACTICE GUIDELINES; EMERGENCY-DEPARTMENT; AMERICAN-ACADEMY; DRUG; URINE; IMMUNOASSAY; METHANOL; THERAPY;
D O I
10.1016/j.cca.2013.09.039
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Recent upward trends in the prevalence of abuse of prescription drugs and illicit substances have resulted in increased demands for toxicology testing to support the emergency department and drug treatment in pain management programs. This review will discuss the challenges faced by clinical laboratories to manage the utilization of toxicology tests, particularly those ordered in managing poisoned patients in the emergency department and chronic pain patients on opioid therapy. Optimal utilization of toxicology tests to support the emergency department relies on selecting the appropriate tests for the patient, and the availability of the results in a timely fashion. Two tiers of toxicology testing systems with different requirements for turnaround time will be discussed. In patients with chronic pain urine drug testing, including screening and confirmation testing are used extensively in pain management to monitor patient compliance. A thorough understanding of the performance characteristics of the test methodologies and drug metabolism is a key to making a proper analytical and clinical interpretation of the test results and will contribute to effective utilization of these tests. In addition, the reimbursement system is an important factor in the derision making process for test selection utilization as significant costs can be incurred by both payers and patients. Collaboration, trust, and effective communication among clinicians, patients, and clinical laboratory professionals are essential for effective utilization of toxicology testing. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 61 条
[1]  
[Anonymous], 2012, Results from the 2011 national survey on drug use and health: Summary of national findings
[2]  
[Anonymous], 2011, VAL CLIN LAB SERV HL
[3]  
[Anonymous], UN DRUG POIS US
[4]   Quinolones and false-positive urine screening for opiates by immunoassay technology [J].
Baden, LR ;
Horowitz, G ;
Jacoby, H ;
Eliopoulos, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24) :3115-3119
[5]  
Bailey DN, 1996, AM J CLIN PATHOL, V105, P572
[6]   Why Is Urine Drug Testing Not Used More Often in Practice? [J].
Bair, Matthew J. ;
Krebs, Erin E. .
PAIN PRACTICE, 2010, 10 (06) :493-496
[7]  
Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P537
[8]  
Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415
[9]  
Baskin L B, 1997, Tex Med, V93, P50
[10]   The utility of toxicologic analysis in children with suspected ingestions [J].
Belson, MG ;
Simon, HK ;
Sullivan, K ;
Geller, RJ .
PEDIATRIC EMERGENCY CARE, 1999, 15 (06) :383-387